A University of Toronto research team from the Department of Chemistry has discovered useful “green” catalysts made from iron that might replace the much more expensive and toxic platinum metals typically used in industrial chemical processes to produce drugs, fragrances and flavours. The synthesis of drugs usually relies on the use of catalysts and the expense of the catalysts influences the ultimate cost of the drug. pharmaceutical distribution
Genentech, Inc. announced a phased voluntary withdrawal of the psoriasis drug Raptiva® (efalizumab) from the U.S. market. The company’s decision is based on the association of Raptiva with an increased risk of progressive multifocal leukoencephalopathy (PML), a rare and usually fatal disease of the central nervous system. pharmaceutical distribution
Johns Hopkins University School of Medicine has instituted a new policy “on interaction with industry” that prohibits no-cost drug samples and gifts, limits interaction with drug and device company representatives and prohibits physicians from participating in consulting jobs for which they do little to no work, the Wall Street Journal’s ” pharmaceutical distribution
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version for Bayer Healthcare Pharmaceuticals’ oral contraceptive Yaz® (Drospirenone and Ethinyl Estradiol) Tablets. As the first company to file an ANDA containing a paragraph IV certification for this product, Teva has been awarded a 180-day period of marketing exclusivity. pharmaceutical distribution
Tianyin Pharmaceutical Co., Inc. Series A Preferred Shareholders Approved Cash Dividend to Common Stockholders (PR Newswire Finance)Tianyin Pharmaceutical, Co., Inc., , a manufacturer and supplier of modernized traditional Chinese medicine based in Chengdu, China, today announced that its Series A Preferred shareholders approved an annual cash dividend of $0.10 per common share that will be paid quarterly for each quarter of this fiscal year.
GoIP Launches New State-of-the-Art Wireless Survey Device at Advertising Research Foundation Show (Marketwire Finance)GoIP Global, Inc. announced the launch of a new state-of-the-art Wireless Survey Device, Xit Poll(TM). GoIP is offering Xit Poll(TM) under an exclusive nationwide distribution agreement with Cleva Technologies LLC. At last week’s Advertising Research Foundation Convention & Trade Show in New York, GoIP unveiled Xit Poll(TM) and received an over-whelming response from major household corporations .
The pharmaceutical industry is a priority target market for IBS. The company works with major pharmaceutical companies to distribute some of the most carefully controlled . Pharmaceutical Distribution Software IBS/AMERICAS
